Liang-ping Zhou

Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study

D. Ye, Hai-Liang Zhang, G. Shi, 2015, Oncotarget.

Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma

D. Ye, Hai-Liang Zhang, G. Shi, 2018, International journal of urology : official journal of the Japanese Urological Association.

Prognostic value of pathological features of primary lesion in metastatic renal cell carcinoma treated with sorafenib.

D. Ye, Hai-Liang Zhang, Yao Zhu, 2016, Future oncology.

Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma.

X. Yao, B. Dai, Yi-jun Shen, 2013, The Journal of urology.